ArticlePhysics and imaging in radiation oncology2026
Photon-counting detector computing tomography in treatment planning of head-and-neck cancer.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of beam hardening on proton stopping-power ratio estimation using photon-counting, dual-energy, and single-energy computed tomography.Physics and imaging in radiation oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Photon-counting detector computed tomography (PCD-CT) offers several image reconstruction options, e.g. virtual monoenergetic images (VMIs) and relative electron density (RED) images. This study investigated these PCD-CT reconstructions for dose calculation in head-and-neck cancer (HNC) patients. Materials and methods: 10 HNC patients referred to radiotherapy were scanned with PCD-CT. The same contouring and therapy strategy was followed as in the patients' clinical treatment, optimized on an energy-integrated-detector CT (EID-CT). 18 volumetric arc therapy treatment plans (6 MV photons) were optimized on RED images and recalculated on 70 keV VMI (VMI70), using the same amount of monitor units. While RED images did not require scanner-specific calibration, the conversion from CT number to RED for VMI70 was calibrated using a phantom with tissue-equivalent inserts with known RED. To assess the clinical impact of using RED maps with vendor-provided calibration, one plan per patient was recalculated using bulk material overrides. Plan quality was evaluated by evaluating dose-volume metrics, such as the dose to 98% of planning target volume, and compared between RED, VMI70, and EID-CT. Results: All plans optimized on RED images fulfilled the clinical goals. Dose-volume metrics differed by <3% between RED and VMI70 and <5% between RED and EID-CT. RED differed by differed by <4% from bulk density override (<1% when the target did not overlap with air volumes). Conclusions: Treatment planning can be accurately performed on PCD-CT images of HNC cases, using either VMI (after CT-number-to-RED conversion) or RED images (without scanner-specific calibration).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.